05.26.2022
The CDC has released guidance on the potential for recurrence of COVID-19 or “COVID-19 rebound” after Paxlovid treatment.
- There is currently no evidence that additional treatment for COVID-19 is needed for COVID-19 rebound.
- People who test positive for COVID-19 again after taking the drug Paxlovid should isolate for another 5 days.
- Consider clinical evaluation of patients who have COVID-19 rebound and symptoms that persist or worsen.
- Providers are asked to report cases of COVID-19 rebound to Pfizer and FDA.